المؤلفون: Moore T., Seymour J.F., Townsend W., Trneny M., Wenger M., Fingerle-Rowson G., Rufibach K., Herold M., Hiddemann W., Marcus R., Davies A., Ando K., Klapper W., Opat S., Owen C., Phillips E., Sangha R., Schlag R.

مصطلحات الفهرس: infection/si [Side Effect], infusion related reaction/si [Side Effect], intention to treat analysis, major clinical study, male, multiple cycle treatment, myelodysplastic syndrome/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], non melanoma skin cancer/si [Side Effect], primary health care, priority journal, progression free survival, cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/ct [Clinical Trial], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], obinutuzumab/ct [Clinical Trial], obinutuzumab/dt [Drug Therapy], obinutuzumab/iv [Intravenous Drug Administration], prednisone/ae [Adverse Drug Reaction], prednisone/ct [Clinical Trial], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/ae [Adverse Drug Reaction], rituximab/ct [Clinical Trial], rituximab/dt [Drug Therapy], vincristine/ae [Adverse Drug Reaction], vincristine/ct [Clinical Trial], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], randomized controlled trial, second cancer/si [Side Effect], thrombocytopenia/si [Side Effect], treatment outcome, treatment response, tumor lysis syndrome/si [Side Effect], very elderly, bendamustine/ae [Adverse Drug Reaction], bendamustine/ct [Clinical Trial], bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], adult, aged, article, bleeding disorder/si [Side Effect], cancer grading, cancer growth, cancer immunotherapy, cancer recurrence, cardiovascular disease/si [Side Effect], controlled study, digestive system perforation/si [Side Effect], female, follicular lymphoma/dt [Drug Therapy], hematologic malignancy/si [Side Effect], human, induction chemotherapy, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38731
New England Journal of Medicine
Click here for full text options
LibKey Link

المؤلفون: Moore T., Seymour J.F., Townsend W., Trneny M., Wenger M., Fingerle-Rowson G., Rufibach K., Herold M., Hiddemann W., Marcus R., Davies A., Ando K., Klapper W., Opat S., Owen C., Phillips E., Sangha R., Schlag R.

مصطلحات الفهرس: infection/si [Side Effect], infusion related reaction/si [Side Effect], intention to treat analysis, major clinical study, male, multiple cycle treatment, myelodysplastic syndrome/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], non melanoma skin cancer/si [Side Effect], primary health care, priority journal, progression free survival, cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/ct [Clinical Trial], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], obinutuzumab/ct [Clinical Trial], obinutuzumab/dt [Drug Therapy], obinutuzumab/iv [Intravenous Drug Administration], prednisone/ae [Adverse Drug Reaction], prednisone/ct [Clinical Trial], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/ae [Adverse Drug Reaction], rituximab/ct [Clinical Trial], rituximab/dt [Drug Therapy], vincristine/ae [Adverse Drug Reaction], vincristine/ct [Clinical Trial], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], randomized controlled trial, second cancer/si [Side Effect], thrombocytopenia/si [Side Effect], treatment outcome, treatment response, tumor lysis syndrome/si [Side Effect], very elderly, bendamustine/ae [Adverse Drug Reaction], bendamustine/ct [Clinical Trial], bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], adult, aged, article, bleeding disorder/si [Side Effect], cancer grading, cancer growth, cancer immunotherapy, cancer recurrence, cardiovascular disease/si [Side Effect], controlled study, digestive system perforation/si [Side Effect], female, follicular lymphoma/dt [Drug Therapy], hematologic malignancy/si [Side Effect], human, induction chemotherapy, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38731
New England Journal of Medicine
Click here for full text options
LibKey Link

المؤلفون: Truman M., Marlton P., Catalano J., Tran H., Brighton T., Grigg A., Mcrae S., Dixon J., Thurley D., Gandhi M.K.

مصطلحات الفهرس: idiopathic thrombocytopenic purpura/dt [Drug Therapy], intention to treat analysis, major clinical study, male, medication therapy management, multicenter study, multiple cycle treatment, myelodysplastic syndrome/si [Side Effect], open study, oropharynx pain/si [Side Effect], patient compliance, petechia/si [Side Effect], phase 2 clinical trial, Pneumocystis pneumonia/si [Side Effect], priority journal, prospective study, rash/si [Side Effect], refractory thrombocytopenia/dt [Drug Therapy], relapse/dt [Drug Therapy], rhinopharyngitis/si [Side Effect], subdural hematoma/si [Side Effect], thorax pain/si [Side Effect], thrombocyte count, time to treatment, treatment duration, treatment refusal, upper respiratory tract infection/si [Side Effect], rituximab/ct [Clinical Trial], rituximab/do [Drug Dose], rituximab/dt [Drug Therapy], rituximab/pd [Pharmacology], rituximab/ae [Adverse Drug Reaction], adult, aged, article, contusion/si [Side Effect], diarrhea/si [Side Effect], dosage schedule comparison, dose response, drug effect, drug efficacy, drug fatality/si [Side Effect], drug indication, drug safety, drug tolerability, drug treatment failure, dyspnea/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, follow up, headache/si [Side Effect], human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41975
British Journal of Haematology
Click here for full text options
LibKey Link

المؤلفون: Truman M., Marlton P., Catalano J., Tran H., Brighton T., Grigg A., Mcrae S., Dixon J., Thurley D., Gandhi M.K.

مصطلحات الفهرس: idiopathic thrombocytopenic purpura/dt [Drug Therapy], intention to treat analysis, major clinical study, male, medication therapy management, multicenter study, multiple cycle treatment, myelodysplastic syndrome/si [Side Effect], open study, oropharynx pain/si [Side Effect], patient compliance, petechia/si [Side Effect], phase 2 clinical trial, Pneumocystis pneumonia/si [Side Effect], priority journal, prospective study, rash/si [Side Effect], refractory thrombocytopenia/dt [Drug Therapy], relapse/dt [Drug Therapy], rhinopharyngitis/si [Side Effect], subdural hematoma/si [Side Effect], thorax pain/si [Side Effect], thrombocyte count, time to treatment, treatment duration, treatment refusal, upper respiratory tract infection/si [Side Effect], rituximab/ct [Clinical Trial], rituximab/do [Drug Dose], rituximab/dt [Drug Therapy], rituximab/pd [Pharmacology], rituximab/ae [Adverse Drug Reaction], adult, aged, article, contusion/si [Side Effect], diarrhea/si [Side Effect], dosage schedule comparison, dose response, drug effect, drug efficacy, drug fatality/si [Side Effect], drug indication, drug safety, drug tolerability, drug treatment failure, dyspnea/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, follow up, headache/si [Side Effect], human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41975
British Journal of Haematology
LibKey Link